Health Care & Life Sciences » Pharmaceuticals | Yungjin Pharm. Co. Ltd.

Yungjin Pharm. Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
156,623
167,569
170,203
193,134
195,009
186,409
Cost of Goods Sold (COGS) incl. D&A
100,424
106,635
105,605
122,166
126,536
125,420
Gross Income
56,198
60,935
64,598
70,968
68,472
60,989
SG&A Expense
48,472
53,117
58,630
64,465
64,392
62,091
EBIT
6,917
6,976
5,048
5,454
3,029
2,187
Unusual Expense
1,910
-
-
-
-
4,830
Non Operating Income/Expense
7,141
46
302
622
129
502
Interest Expense
1,187
661
870
787
463
273
Pretax Income
11,038
6,462
4,551
5,324
2,788
6,652
Income Tax
704
5,553
1,165
1,122
921
551
Consolidated Net Income
11,742
909
3,386
4,202
1,868
6,101
Net Income
11,742
909
3,386
4,202
1,868
6,101
Net Income After Extraordinaries
11,742
909
3,386
4,202
1,868
6,101
Net Income Available to Common
11,742
909
3,386
4,202
1,868
6,101
EPS (Basic)
66.00
5.00
19.00
24.00
10.00
33.36
Basic Shares Outstanding
178
178
178
178
183
183
EPS (Diluted)
66.11
5.12
19.06
23.66
10.22
33.36
Diluted Shares Outstanding
178
178
178
178
183
183
EBITDA
11,812
11,891
10,910
11,284
9,631
4,455
Other Operating Expense
810
842
920
1,048
1,052
1,086
Non-Operating Interest Income
78
100
71
35
93
136

About Yungjin Pharm. Co.

View Profile
Address
13 Olympic-ro 35da-gil
Seoul SL 05510
Korea, Republic Of
Employees -
Website http://www.yungjin.co.kr
Updated 07/08/2019
Yungjin Pharm. Co., Ltd. engages in the development, production, and distribution of pharmaceuticals. Its products include cephalosporin, antibiotics, drugs for the central nervous system, cardiovascular, endocrine system, urinary system, respiratory, anti-inflammatory and analgesics, anti-histamine, anti-fungal, total nutrition, vitamin and supplement, cosmetics, and tonic drinks.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.